Protagonist Therapeutics shares owned by Credit Suisse
Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Protagonist Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protagonist Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protagonist Therapeutics by Credit Suisse
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.4M | 63k | 22.93 |
| 2023-09-30 | $836k | 50k | 16.68 |
| 2023-06-30 | $1.7M | 63k | 27.62 |
| 2023-03-31 | $874k | 38k | 23.00 |
| 2022-12-31 | $341k | 31k | 10.91 |
| 2022-09-30 | $269k | 32k | 8.38 |
| 2022-06-30 | $248k | 32k | 7.78 |
| 2022-03-31 | $784k | 33k | 23.83 |
| 2021-12-31 | $970k | 28k | 34.22 |
| 2021-09-30 | $484k | 28k | 17.48 |
| 2021-06-30 | $1.2M | 28k | 44.61 |
| 2021-03-31 | $434k | 21k | 20.41 |
| 2020-12-31 | $1.5M | 51k | 30.30 |
| 2020-09-30 | $544k | 28k | 19.79 |
| 2016-09-30 | $357k | 17k | 21.11 |